The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on ^sup 18^F-FDG Uptake of Primary Breast Cancer Lesions

The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before unde...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of nuclear medicine (1978) Vol. 48; no. 8; p. 1266
Main Authors Mavi, Ayse, Cermik, Tevfik F, Urhan, Muammer, Puskulcu, Halis
Format Journal Article
LanguageEnglish
Published New York Society of Nuclear Medicine 01.08.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson X2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, x2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (x2 = 71.054,P< 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (x2 = 13.026, P < 0.01 ). No relationship was detected between PR and C-erbB-2R states (?2 = 3.695, P > 0.05). ANOVAs showed that PR state atañe (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18FFDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. [PUBLICATION ABSTRACT]
ISSN:0161-5505
1535-5667